Author:
Webb Nicholas J A,Frew Emma,Brettell Elizabeth A,Milford David V,Bockenhauer Detlef,Saleem Moin A,Christian Martin,Hall Angela S,Koziell Ania,Maxwell Heather,Hegde Shivram,Finlay Eric R,Gilbert Rodney D,Booth Jenny,Jones Caroline,McKeever Karl,Cook Wendy,Ives Natalie J
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference14 articles.
1. McKinney PA, Feltblower RG, Brocklebank JT, Fitzpatrick MM: Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001, 15: 1040-1044.
2. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS: Long-term outcome for children with minimal change nephrotic syndrome. Lancet. 1985, 1: 368-370.
3. Shenoy M, Plant ND, Lewis MA, Bradbury MG, Lennon R, Webb NJ: Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol. 2010, 25 (5): 899-903. 10.1007/s00467-009-1417-1.
4. International Study of Kidney Disease in Children: Nephrotic syndrome in children: a randomised controlled trial comparing two prednisone regimens in steroid-responsive patients who relapse early. J Pediatr. 1982, 95: 239-243.
5. Webb NJA: Epidemiology and general management of childhood idiopathic nephrotic syndrome. Evidence-based Nephrology. Edited by: Molony D, Craig J. 2008, Oxford, UK: Wiley-Blackwell